Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan plus amlodipine dose-strategy study in uncontrolled hypertension
2005-005010-20Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of valsartan, amlodipine in hypertension (HTN), sponsored by Novartis. Started Dec 2005; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2005-005010-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005010-20.